PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
One RCT showed significant effects of moxibustion (burning A. vulgaris) as an adjunct treatment to antihypertensive drug therapy for lowering blood pressure, though other RCTs failed to report favorable effects [PMID:20602794].
Moxibustion using A. vulgaris to stimulate acupuncture points reported a success rate of 84.6% for inducing cephalic version after 34 weeks gestation, though studies were small and not randomised [PMID:11926602].
A review identified A. vulgaris as having high xanthine oxidase inhibitory activity (>85%) [PMID:29628890].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32992959 (2020) — Significance of Artemisia Vulgaris L. (Common Mugwort) in the History of Medicine and Its Possible Contemporary Applications Substantiated by Phytochemical and Pharmacological Studies. · Molecules (Basel, Switzerland)
- 2.PMID: 3331270 (1987) — [Botany of Artemisia]. · Allergie et immunologie
- 3.PMID: 27222528 (2016) — Sunflower seed allergy. · International journal of immunopathology and pharmacology
- 4.PMID: 29628890 (2018) — Anti-gout Potential of Malaysian Medicinal Plants. · Frontiers in pharmacology
- 5.PMID: 40718489 (2025) — Intranasal monoclonal antibodies to mugwort pollen reduce allergic inflammation in a mouse model of allergic rhinitis and asthma.